CG MedTech Co.,Ltd. (KOSDAQ:056090)
South Korea · Delayed Price · Currency is KRW 1,165.00
+26.00 (2.28%)
At close: Sep 4, 2026
CG MedTech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 120,297 | 120,607 | 104,085 | 93,078 | 93,078 | 45,362 | |
Market Cap Growth | 14.44% | 15.87% | 11.82% | 0% | 105.19% | 26.28% |
Enterprise Value | 130,245 | 107,876 | 86,327 | 84,503 | 65,855 | 55,847 |
Last Close Price | 1165.00 | 1168.00 | 1008.00 | 1180.00 | 1180.00 | 985.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.05 | 18.53 | 1743.71 | 57.14 | - | - |
Forward PE | - | 26.54 | 26.54 | 26.54 | 26.54 | 26.54 |
PS Ratio | 2.35 | 2.55 | 3.01 | 2.66 | 2.26 | 1.19 |
PB Ratio | 1.25 | 1.28 | 1.20 | 1.55 | 1.61 | 1.58 |
P/TBV Ratio | 1.42 | 1.45 | 1.26 | 1.58 | 1.66 | 1.69 |
P/FCF Ratio | - | - | 141.29 | - | - | 120.94 |
P/OCF Ratio | - | 46.16 | 68.90 | - | - | 36.66 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.54 | 2.28 | 2.49 | 2.42 | 1.60 | 1.47 |
EV/EBITDA Ratio | 26.78 | 17.78 | 144.82 | 20.83 | - | 41.45 |
EV/EBIT Ratio | 69.43 | 28.37 | - | 38.34 | - | - |
EV/FCF Ratio | - | - | 117.18 | - | - | 148.90 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.21 | 0.05 | 0.05 | 0.07 | 1.14 | 1.04 |
Debt / EBITDA Ratio | 4.22 | 0.71 | 7.43 | 1.08 | - | 22.25 |
Debt / FCF Ratio | - | - | 6.02 | - | - | 79.92 |
Net Debt / Equity Ratio | 0.10 | -0.07 | -0.34 | -0.17 | -0.16 | 0.34 |
Net Debt / EBITDA Ratio | 2.01 | -1.08 | -50.10 | -2.46 | 1.13 | 7.27 |
Net Debt / FCF Ratio | -0.43 | 0.74 | -40.54 | 2.45 | 1.45 | 26.10 |
Asset Turnover | 0.42 | 0.43 | 0.37 | 0.32 | 0.38 | 0.55 |
Inventory Turnover | 1.80 | 1.91 | 1.58 | 1.55 | 2.16 | 2.32 |
Quick Ratio | 0.99 | 1.10 | 3.37 | 2.43 | 1.14 | 1.22 |
Current Ratio | 2.10 | 2.12 | 4.56 | 3.84 | 1.30 | 1.78 |
Return on Equity (ROE) | 7.09% | 7.19% | -0.17% | 2.22% | -43.51% | -18.67% |
Return on Assets (ROA) | 0.96% | 2.14% | -0.73% | 1.25% | -5.88% | -0.73% |
Return on Invested Capital (ROIC) | 1.87% | 5.26% | 19.95% | 4.21% | -23.32% | -2.05% |
Return on Capital Employed (ROCE) | 1.70% | 3.90% | -1.10% | 3.10% | -14.80% | -1.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.45% | 5.40% | 0.06% | 1.75% | -19.92% | -10.96% |
FCF Yield | -18.93% | -7.35% | 0.71% | -4.37% | -6.64% | 0.83% |
Buyback Yield / Dilution | -13.85% | -72.99% | 24.33% | -18.55% | -49.47% | -16.01% |